The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
Journal article
PREISS D. et al, (2021), Diabetes Care
Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017
Conference paper
Thalmann I. et al, (2020), EUROPEAN HEART JOURNAL, 41, 3509 - 3509
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Journal article
Herrington WG. et al, (2020), Clin Kidney J, 13
Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: Meta-analysis of 119 clinical trials involving 100,667 patients
Journal article
PREISS D., (2020), Circulation
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar.
Journal article
Preiss D. et al, (2020), J Am Coll Cardiol, 75, 1945 - 1955
Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance.
Journal article
Coll AP. et al, (2020), Nature, 578
GDF15 mediates the effects of metformin on body weight and energy balance
Journal article
PREISS D., (2019), Nature
CV Care: Lipid-modifying Agents--From Statins to PCSK9 inhibitors
Journal article
PREISS D. and REITH C., (2019), JACC - Journal of the American College of Cardiology
Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome
Conference paper
Schwartz G. et al, (2019), EUROPEAN HEART JOURNAL, 40, 3804 - 3804
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
Journal article
PREISS DJ. et al, (2019), BMC Cardiovascular Disorders
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Journal article
Kristensen SL. et al, (2019), Lancet Diabetes Endocrinol
Cardiovascular, mortality and renal outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes – a systematic review and meta-analysis of randomised trials
Journal article
PREISS DJ., (2019), The Lancet Diabetes and Endocrinology
Research digest: SGLT2 inhibition in kidney and liver disease.
Journal article
Preiss D. and Sattar N., (2019), Lancet Diabetes Endocrinol, 7
Opposite associations of aortic aneurysm with blood glucose and with diabetes
Journal article
BULBULIA RICHARD. et al, (2019), Circulation Journal
Research digest: new insights into established risk pathways.
Journal article
Preiss D. and Sattar N., (2019), Lancet Diabetes Endocrinol, 7
Cardiac Troponin T and Troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes
Journal article
PREISS D. and WOODWARD MARK., (2019), Circulation
Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial
Conference paper
Alramah T. et al, (2019), DIABETIC MEDICINE, 36, 31 - 31
Noval miRNA biomarkers in cardiometabolic disease: Data from the carotid atherosclerosis metformin for insulin resistance (CAMERA) trial
Conference paper
Alghibiwi H. et al, (2019), DIABETIC MEDICINE, 36, 48 - 48
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.
Journal article
Armitage J. et al, (2019), J Am Coll Cardiol, 73, 477 - 487
Efficacy and safety of statin therapy in older people: metaanalysis of individual participant data from 28 randomised controlled trials
Journal article
COLLINS RE. et al, (2019), Lancet